mhurhangee/ep-ind-claims huggingface dataset:
An aircraft assembly comprising: an engine configured to be mounted to an aircraft (102, 202); an intake configured to provide air to the engine, the intake comprising a body having an inlet comprising an inlet opening through which air enters the intake, the intake comprising an intake upstream lip disposed proximate the inlet opening; and a propeller assembly comprising propeller blades coupled to and driven by the engine, the propeller assembly spaced an axial distance from the intake upstream lip of the intake wherein air flowing by the propeller blades enters the intake, the propeller assembly having a propeller configuration, wherein at least a portion of the propeller configuration is at least one of sized or shaped to optimize performance of the propeller assembly based on an interaction between the propeller assembly and the intake; wherein the configuration of the propeller assembly specifies a propeller root trailing edge airfoil shape, characterized in that; the propeller root trailing edge airfoil shape has a profile with a maximum thickness and a trailing edge thickness that is 30% or more of the maximum thickness for at least a portion of the propeller root trailing edge airfoil shape over a spanwise region of the propeller blade that interacts with the inlet air flow. an engine configured to be mounted to an aircraft (102, 202); an intake configured to provide air to the engine, the intake comprising a body having an inlet comprising an inlet opening through which air enters the intake, the intake comprising an intake upstream lip disposed proximate the inlet opening; and a propeller assembly comprising propeller blades coupled to and driven by the engine, the propeller assembly spaced an axial distance from the intake upstream lip of the intake wherein air flowing by the propeller blades enters the intake, the propeller assembly having a propeller configuration, wherein at least a portion of the propeller configuration is at least one of sized or shaped to optimize performance of the propeller assembly based on an interaction between the propeller assembly and the intake; wherein the configuration of the propeller assembly specifies a propeller root trailing edge airfoil shape, characterized in that; the propeller root trailing edge airfoil shape has a profile with a maximum thickness and a trailing edge thickness that is 30% or more of the maximum thickness for at least a portion of the propeller root trailing edge airfoil shape over a spanwise region of the propeller blade that interacts with the inlet air flow.
An aircraft fixed aerodynamic structure assembly comprising: a fixed aerodynamic structure component, a shroud panel, in which the shroud panel is attached to the fixed aerodynamic structure component by a plurality of attachment members, characterised in that each attachment member is connected to the shroud panel by an articulated joint and the fixed aerodynamic structure component by another articulated joint. a fixed aerodynamic structure component, a shroud panel, in which the shroud panel is attached to the fixed aerodynamic structure component by a plurality of attachment members, characterised in that each attachment member is connected to the shroud panel by an articulated joint and the fixed aerodynamic structure component by another articulated joint.
A stable pharmaceutical composition comprising fingolimod, a pharmaceutically acceptable salt thereof or a phosphate derivative thereof, and a zwitterion as a stabilizer, wherein the composition is free of sugar alcohol and wherein the zwitterion is an amino acid.
Suspension fork for a bicycle having a head tube and at least one tube system (3, 4) connected therewith which comprises an inner tube (5, 6) and an outer tube (7, 8) movable relative thereto wherein a wheel receiving space is provided adjacent to the tube system (3, 4), wherein within the tube system (3, 4) a damper device with a damping medium is provided wherein the damper device is provided with a damper chamber and a throttle valve wherein the damper chamber is partitioned to form a first chamber and a second chamber by way of a piston that is movable and connected with a piston rod, and wherein the first chamber is connected with the second chamber via a return duct, the throttle valve, and a transfer duct, wherein the damping medium comprises a magnetorheological fluid and wherein the throttle valve is adjustable, and wherein at least one field generating device is provided for generating a magnetic field in a damping duct of the throttle valve, wherein a one-way circuit is substantially provided for the damping medium in which circuit at least two one-way valves (21, 22) are provided such that both when the piston rod plunges into the damper chamber and when the piston rod retracts out of the damper chamber the damping medium flows in the same direction of circulation wherein a first of the one-way valves is disposed at the piston, allowing a flow of the damping medium from the second chamber into the first chamber, and that at the transfer duct a second one-way valve is disposed allowing a flow of the damping medium from the transfer duct into the second chamber such that both the plunge of the piston rod into the damper chamber and the retraction of the piston rod out of the damper chamber can be selectively controlled by means of the adjustable throttle valve, wherein an insert device is provided between the tube system and the damper chamber, wherein at least portions of the return duct are provided at the insert device and preferably define the flow cross-section of the return duct, characterized in that a mean density of the insert device between the tube system (3, 4) is lower than a mean density of the damping medium.
An aqueous solution single unit dose amount, consisting essentially of the following components: (a) 350 to 600g/L PEG having an average molecular weight of 2500 to 4500 Da; (b) 8.0 to 20 g/L sodium chloride; (c) 1.0 to 3.0 g/L potassium chloride; (d) 3.0 to 11 g/L sodium bicarbonate; (e) optional sweetener; and (f) optional flavouring, the solution being substantially free from added preservative, for use in a method of treating constipation and/or faecal impaction in a mammalian subject, such as a human, comprising orally administering the solution without further dilution. (a) 350 to 600g/L PEG having an average molecular weight of 2500 to 4500 Da; (b) 8.0 to 20 g/L sodium chloride; (c) 1.0 to 3.0 g/L potassium chloride; (d) 3.0 to 11 g/L sodium bicarbonate; (e) optional sweetener; and (f) optional flavouring, the solution being substantially free from added preservative, for use in a method of treating constipation and/or faecal impaction in a mammalian subject, such as a human, comprising orally administering the solution without further dilution.
A method for the separation of particles of at least a first and second type comprising the steps of: i. generating a force field characterized by at least one point of stable equilibrium within which said particles (FP, SP) are attracted; and ii. making at least one movement in space of said at least one point of stable equilibrium; whereby the particles of said first type are subjected to follow the movement in space of said at least one point of stable equilibrium with a first speed of movement; and the particles of said second type are subjected to follow the movement in the space of said at least one point of stable equilibrium with a second speed of movement lower than the first speed; wherein - said at least one movement of the at least one point of stable equilibrium is carried out with a speed substantially comparable with the first speed of movement, and substantially different from the second speed of movement for a time interval sufficient to let the particles of the first type to follow the translation of said at least one point of stable equilibrium continuously and to let the particles of the second type to be left lagging behind, progressively less and less attracted towards said at least one point of stable equilibrium, so as to be effectively separated from the particles of the first type; - said force field being generated by at least one array of electrodes, substantially planar, made on a first substrate. i. generating a force field characterized by at least one point of stable equilibrium within which said particles (FP, SP) are attracted; and ii. making at least one movement in space of said at least one point of stable equilibrium; - said at least one movement of the at least one point of stable equilibrium is carried out with a speed substantially comparable with the first speed of movement, and substantially different from the second speed of movement for a time interval sufficient to let the particles of the first type to follow the translation of said at least one point of stable equilibrium continuously and to let the particles of the second type to be left lagging behind, progressively less and less attracted towards said at least one point of stable equilibrium, so as to be effectively separated from the particles of the first type; - said force field being generated by at least one array of electrodes, substantially planar, made on a first substrate.
A collapsible inhaler for use with a metered dose inhaler dispenser that is operable to dispense a metered dose of medicament therefrom, the inhaler comprising: an inlet member being adapted to receive an MDI dispenser and having an inlet therein; an outlet member comprising an outlet therein, a conduit which has a distal end associated with the inlet member and a proximal end associated with the outlet member, a support associated with the conduit that is adjustable between an expanded state and a contracted state whereby in the contracted state the inlet member is positioned proximate the outlet member, while in the expanded state the support supports the conduit and combined with the inlet member being spaced from the outlet member that defines a chamber, so that in use a metered dose of medicament can be dispensed from the MDI dispenser through the inlet in the inlet member to mix with air in the chamber and be inhaled by a patient through the outlet in the outlet member; characterised in that: the inhaler further comprises a lockout mechanism for inhibiting operation of the MDI dispenser when the support and conduit are in the contracted state and not inhibiting operation of the MDI dispenser when the support and conduit are in the expanded state; and the conduit is pliable. an inlet member being adapted to receive an MDI dispenser and having an inlet therein; an outlet member comprising an outlet therein, a conduit which has a distal end associated with the inlet member and a proximal end associated with the outlet member, a support associated with the conduit that is adjustable between an expanded state and a contracted state whereby in the contracted state the inlet member is positioned proximate the outlet member, while in the expanded state the support supports the conduit and combined with the inlet member being spaced from the outlet member that defines a chamber, so that in use a metered dose of medicament can be dispensed from the MDI dispenser through the inlet in the inlet member to mix with air in the chamber and be inhaled by a patient through the outlet in the outlet member; characterised in that: the inhaler further comprises a lockout mechanism for inhibiting operation of the MDI dispenser when the support and conduit are in the contracted state and not inhibiting operation of the MDI dispenser when the support and conduit are in the expanded state; and the conduit is pliable.
Method for applying indicia to empty, thin-walled bottles or containers of that kind, by using a container treatment machine having a plurality of treatment positions on a circumferential transport element, such as a rotor circulating about a vertical machine axis MA, wherein the containers on the treatment positions, clamped between a container support and a centering cone of a centering element with a container clamping force, can be moved past at least one aggregate device for applying one or more indicia, and, for the stabilisation of the container, the container can be pretensioned, controlled by means of a control valve, with the pressure (p) of a gaseous and/or vaporous pressure or support medium, and specifically by means of the centering cone closing a container opening (2.1) of the respective container, characterised in that the clamping of each container takes place in a first phase with a reduced first container clamping force and/or with a reduced first rise in the container clamping force, that, before the ending of the first phase, the control valve provided in the centering element is opened by the container clamping force, taking effect between the container and the centering cone for pretensioning the container with a gaseous and/or vaporous pressure medium, and that in a second phase following the first phase, the further clamping of the containers is effected with an increased second container clamping force and/or with an increased second rise in the container clamping force.
Method for three-dimensionally printing a sleeve intended to receive a cosmetic applicator, comprising: a) a step of receiving dimensions of a finger of a user, b) a calculation step to adapt the dimensions of the sleeve to be printed to the finger of the user, c) a step of three-dimensionally printing said sleeve using a three-dimensional printing device, said sleeve having a main longitudinal extension direction, called main direction, a proximal end, by which the user introduces their finger, and a distal end, opposite said proximal end along said main direction, in the vicinity of which the sleeve comprises a seat intended to receive said cosmetic applicator, said cosmetic applicator being made in one piece with said sleeve, said sleeve comprising an inner space dictated by the shape of the finger of the user, the dimensions of the sleeve corresponding to the dimensions of said finger of the user, thanks to which each sleeve is adapted to the particular morphology of the user. a) a step of receiving dimensions of a finger of a user, b) a calculation step to adapt the dimensions of the sleeve to be printed to the finger of the user, c) a step of three-dimensionally printing said sleeve using a three-dimensional printing device, said sleeve having a main longitudinal extension direction, called main direction, a proximal end, by which the user introduces their finger, and a distal end, opposite said proximal end along said main direction, in the vicinity of which the sleeve comprises a seat intended to receive said cosmetic applicator, said cosmetic applicator being made in one piece with said sleeve, said sleeve comprising an inner space dictated by the shape of the finger of the user, the dimensions of the sleeve corresponding to the dimensions of said finger of the user, thanks to which each sleeve is adapted to the particular morphology of the user.
A method for detecting one or more mechanical properties of at least one of a plurality of cells in a sample, the method comprising: acquiring a data set for at least one metric of mechanical signatures of the at least one of a plurality of cells using a label-free spectroscopy-based cytometry, wherein the mechanical signatures are selected from the group consisting of: modulus, stiffness, viscosity, compressibility, electrostriction and a combination thereof; generating at least one histogram representing the mechanical signature of the plurality of cells based on the acquired data set, the at least one histogram providing the number of cells for each of a plurality of metric values present in the data set; determining from each of the at least one histogram the sensitivity and specificity of the data set for the plurality of the metric values; calculating a merit function based on sensitivity and specificity of the data set; locating the peak of the merit function, wherein the optimal metric value that corresponds to the peak of the merit function is the optimal metric value and corresponds to the ratio between sensitivity and (1 - specificity); applying the optimal metric value as a threshold to optimize the data set as depicted in the histogram, and determine true positive and false positive data points; and classifying the at least one of a plurality of cells based on the mechanical signature associated with the histogram and the optimal metric value. acquiring a data set for at least one metric of mechanical signatures of the at least one of a plurality of cells using a label-free spectroscopy-based cytometry, wherein the mechanical signatures are selected from the group consisting of: modulus, stiffness, viscosity, compressibility, electrostriction and a combination thereof; generating at least one histogram representing the mechanical signature of the plurality of cells based on the acquired data set, the at least one histogram providing the number of cells for each of a plurality of metric values present in the data set; determining from each of the at least one histogram the sensitivity and specificity of the data set for the plurality of the metric values; calculating a merit function based on sensitivity and specificity of the data set; locating the peak of the merit function, wherein the optimal metric value that corresponds to the peak of the merit function is the optimal metric value and corresponds to the ratio between sensitivity and (1 - specificity); applying the optimal metric value as a threshold to optimize the data set as depicted in the histogram, and determine true positive and false positive data points; and classifying the at least one of a plurality of cells based on the mechanical signature associated with the histogram and the optimal metric value.
A method comprising: receiving a multimedia content stream comprising a series of segments, each segment corresponding to a respective predicted seek position of a plurality of predicted seek positions in the multimedia content stream, wherein at least two versions of each segment are provided, each version reconstructed from at least one encoded component of the multimedia content stream, the versions having varying bitrates; determining a likelihood of receiving a seek request from a user to move from a current playout position in the multimedia content stream to one of the predicted seek positions in the multimedia content stream; and determining, by a processor, a size of a buffer for each segment in the multimedia content stream based on the likelihood of receiving the seek request, wherein determining of the size of the buffer for each segment is further based on a priority ordering of the versions for each segment in the multimedia content stream. receiving a multimedia content stream comprising a series of segments, each segment corresponding to a respective predicted seek position of a plurality of predicted seek positions in the multimedia content stream, wherein at least two versions of each segment are provided, each version reconstructed from at least one encoded component of the multimedia content stream, the versions having varying bitrates; determining a likelihood of receiving a seek request from a user to move from a current playout position in the multimedia content stream to one of the predicted seek positions in the multimedia content stream; and determining, by a processor, a size of a buffer for each segment in the multimedia content stream based on the likelihood of receiving the seek request, wherein determining of the size of the buffer for each segment is further based on a priority ordering of the versions for each segment in the multimedia content stream.
A compound which is represented by the following general formula and has a molecular weight of 400 or higher: wherein R 21 and R 22 are bonded to each other to represent a group represented by -CH=CH- or -CH 2 -CH 2 -; Ar b represents an aromatic hydrocarbon ring group which may have a substituent, wherein the substituent of Ar b is selected from monovalent aromatic hydrocarbon ring groups derived from 5- or 6-membered monocycles or di- to pentacyclic fused rings; monovalent aromatic heterocyclic groups derived from 5- or 6-membered monocycles or di- to tetracyclic fused rings; and arylamino groups having an aromatic hydrocarbon ring group with 6 to 12 carbon atoms, wherein the hydrocarbon chain portions in the substituent of Ar b have 1 to 3 carbon atoms; d represents an integer of 1 to 4; when a plurality of Ar b s are contained in the molecule, the Ar b s may be the same or different; and with the proviso that the compound which is represented by the general formula is not R 21 and R 22 are bonded to each other to represent a group represented by -CH=CH- or -CH 2 -CH 2 -; Ar b represents an aromatic hydrocarbon ring group which may have a substituent, wherein the substituent of Ar b is selected from monovalent aromatic hydrocarbon ring groups derived from 5- or 6-membered monocycles or di- to pentacyclic fused rings; monovalent aromatic heterocyclic groups derived from 5- or 6-membered monocycles or di- to tetracyclic fused rings; and arylamino groups having an aromatic hydrocarbon ring group with 6 to 12 carbon atoms, wherein the hydrocarbon chain portions in the substituent of Ar b have 1 to 3 carbon atoms; d represents an integer of 1 to 4; when a plurality of Ar b s are contained in the molecule, the Ar b s may be the same or different; and with the proviso that the compound which is represented by the general formula is not
Use of a polymer for promoting soil release during laundering of a textile fabric, characterised in that the polymer has the general formula I:- in which each SU represents a sugar unit in a polysaccharide backbone; the polysaccharide backbone being selected from the group consisting of xyloglucans, glucomannans, galactomannans; a represents the number of unsubstituted sugar units as a percentage of the total number of sugar units and is in the range from 0 to 99.9%, preferably 65 to 99%, more preferably 80 to 99%; b represents the number of substituted sugar units as a percentage of the total number of sugar units and is in the range from 0.1 to 100%, preferably 1 to 35%, more preferably 1 to 20%; m represents the degree of substitution per sugar unit and is from 1 to 3; L represents an ester or ether linkage; R 1 represents and an alkyl group, which is a branched or unbranched saturated hydrocarbon group which contains from 1 to 12 carbon atoms substituted by a group selected from -OH, -CO-OR 2 where R 2 represents a hydrogen atom or an alkali metal, preferably a sodium or potassium, atom. in which each SU represents a sugar unit in a polysaccharide backbone; the polysaccharide backbone being selected from the group consisting of xyloglucans, glucomannans, galactomannans; a represents the number of unsubstituted sugar units as a percentage of the total number of sugar units and is in the range from 0 to 99.9%, preferably 65 to 99%, more preferably 80 to 99%; b represents the number of substituted sugar units as a percentage of the total number of sugar units and is in the range from 0.1 to 100%, preferably 1 to 35%, more preferably 1 to 20%; m represents the degree of substitution per sugar unit and is from 1 to 3; L represents an ester or ether linkage; R 1 represents and an alkyl group, which is a branched or unbranched saturated hydrocarbon group which contains from 1 to 12 carbon atoms substituted by a group selected from -OH, -CO-OR 2 where R 2 represents a hydrogen atom or an alkali metal, preferably a sodium or potassium, atom.